Research programme: regenerative cardiovascular therapeutics - RecardioAlternative Names: REC 04
Latest Information Update: 08 Jan 2016
At a glance
- Originator RECARDIO
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Unspecified
Most Recent Events
- 08 Jan 2016 Investigation in Undefined indication in Austria (unspecified route)